Experiences with HEK293: A Human Cell Line

Area of Science:

• Biotechnology
• Cell Line Development
• Viral Safety

Background:

• Recombinant therapeutic protein production relies heavily on human cell lines like HEK293.
• HEK293 cells are known for their susceptibility to a wide range of viral infections.
• Standard viral safety protocols may be insufficient for this cell line.

Purpose of the Study:

• To detail the considerations for using HEK293 cells in therapeutic protein production.
• To emphasize the heightened risk of viral contamination with HEK293 cells.
• To report on a viral contamination incident despite implemented safety measures.

Main Methods:

• Review of standard viral safety practices in cell line production.
• Case study analysis of a viral contamination event in HEK293 cell culture.
• Assessment of HEK293 cell line susceptibility to viral pathogens.

Main Results:

• HEK293 cells require specialized viral safety considerations beyond standard protocols.
• A viral contamination occurred in a production setting despite existing precautions.
• The susceptibility of HEK293 cells to numerous viruses poses a significant biomanufacturing risk.

Conclusions:

• Enhanced and specific viral safety strategies are critical for HEK293 cell-based production.
• Contamination events underscore the limitations of current safety measures for susceptible cell lines.
• Continuous vigilance and improved detection methods are necessary to ensure product safety and process integrity.